Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Type I interferons in host defence and inflammatory diseases
Mary K. Crow, Lars Rönnblom
Lupus Science & Medicine (2019) Vol. 6, Iss. 1, pp. e000336-e000336
Open Access | Times Cited: 104

Showing 1-25 of 104 citing articles:

Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment
Mehmet Soy, Gökhan Keser, Pamir Atagündüz, et al.
Clinical Rheumatology (2020) Vol. 39, Iss. 7, pp. 2085-2094
Open Access | Times Cited: 769
Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, phase 3 trial
Richard Furie, Eric F. Morand, Ian N Bruce, et al.
The Lancet Rheumatology (2019) Vol. 1, Iss. 4, pp. e208-e219
Open Access | Times Cited: 352
Pathogenesis and treatment of cytokine storm in COVID-19
Mehmet Soy, Gökhan Keser, Pamir Atagündüz
TURKISH JOURNAL OF BIOLOGY (2021) Vol. 45, Iss. SI-1, pp. 372-389
Open Access | Times Cited: 229
Type I interferon transcriptional network regulates expression of coinhibitory receptors in human T cells
Tomokazu S. Sumida, Shai Dulberg, Jonas C. Schupp, et al.
Nature Immunology (2022) Vol. 23, Iss. 4, pp. 632-642
Open Access | Times Cited: 100
The interplay between cytokines, inflammation, and antioxidants: mechanistic insights and therapeutic potentials of various antioxidants and anti-cytokine compounds
Nitish Kumar Bhol, Madhabi M. Bhanjadeo, Anup K. Singh, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117177-117177
Open Access | Times Cited: 74
Sex differences in neutrophil biology modulate response to type I interferons and immunometabolism
Sarthak Gupta, Shuichiro Nakabo, Luz P. Blanco, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 28, pp. 16481-16491
Open Access | Times Cited: 131
The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19
Gideon Schreiber
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 124
Immunological adaptations in pregnancy that modulate rheumatoid arthritis disease activity
Frauke Förger, Peter M. Villiger
Nature Reviews Rheumatology (2020) Vol. 16, Iss. 2, pp. 113-122
Closed Access | Times Cited: 111
Lyme arthritis: linking infection, inflammation and autoimmunity
Robert B. Lochhead, Klemen Strle, Sheila L. Arvikar, et al.
Nature Reviews Rheumatology (2021) Vol. 17, Iss. 8, pp. 449-461
Open Access | Times Cited: 93
Safety profile of anifrolumab in patients with active SLE: an integrated analysis of phase II and III trials
Raj Tummala, Gabriel Abreu, Lilia Pineda, et al.
Lupus Science & Medicine (2021) Vol. 8, Iss. 1, pp. e000464-e000464
Open Access | Times Cited: 75
Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α
Alexis Mathian, Paul Breillat, Karim Dorgham, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 12, pp. 1695-1703
Open Access | Times Cited: 61
Cytokines and Inflammation in Meniere Disease
Lidia Frejo, José A. López‐Escámez
Clinical and Experimental Otorhinolaryngology (2022) Vol. 15, Iss. 1, pp. 49-59
Open Access | Times Cited: 47
STING-Triggered CNS Inflammation in Human Neurodegenerative Diseases
Alex S. Ferecskó, Miranda J. Smallwood, Adrian Moore, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1375-1375
Open Access | Times Cited: 28
Molecular pathways in patients with systemic lupus erythematosus revealed by gene-centred DNA sequencing
Johanna K. Sandling, Pascal Pucholt, Lina Hultin Rosenberg, et al.
Annals of the Rheumatic Diseases (2020) Vol. 80, Iss. 1, pp. 109-117
Open Access | Times Cited: 57
Antiviral proinflammatory phenotype of monocytes in anti-MDA5 antibody-associated interstitial lung disease
Takahisa Gono, Yuka Okazaki, Masataka Kuwana
Lara D. Veeken (2021) Vol. 61, Iss. 2, pp. 806-814
Closed Access | Times Cited: 41
New insights in systemic lupus erythematosus: From regulatory T cells to CAR-T-cell strategies
Matteo Doglio, Tobias Alexander, Nicoletta Del Papa, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 150, Iss. 6, pp. 1289-1301
Open Access | Times Cited: 29
Disordered cutaneous microbiota in systemic lupus erythematosus
Cancan Huang, Xiaoqing Yi, Hai Long, et al.
Journal of Autoimmunity (2019) Vol. 108, pp. 102391-102391
Closed Access | Times Cited: 50
Cytokines as Biomarkers in Systemic Lupus Erythematosus: Value for Diagnosis and Drug Therapy
Helena Idborg, Vilija Oke
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11327-11327
Open Access | Times Cited: 37
C-Reactive Protein Levels in Systemic Lupus Erythematosus Are Modulated by the Interferon Gene Signature and CRP Gene Polymorphism rs1205
Helena Enocsson, Birgitta Gullstrand, Maija‐Leena Eloranta, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 34
cGAS/cGAMP/STING signal propagation in the tumor microenvironment: Key role for myeloid cells in antitumor immunity
Vera E. Mekers, Vera M. Kho, Marleen Ansems, et al.
Radiotherapy and Oncology (2022) Vol. 174, pp. 158-167
Open Access | Times Cited: 25
Type I interferon gene expression in antiphospholipid syndrome: Pathogenetic, clinical and therapeutic implications
Eleni Xourgia, Maria G. Tektonidou
Journal of Autoimmunity (2019) Vol. 104, pp. 102311-102311
Closed Access | Times Cited: 40
Triggering Receptor Expressed on Myeloid Cell 2 R47H Exacerbates Immune Response in Alzheimer’s Disease Brain
Olena Korvatska, Kostantin Kiianitsa, Alexander V. Ratushny, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 33
Impact of Type I Interferons on Susceptibility to Bacterial Pathogens
Adeline Peignier, Dane Parker
Trends in Microbiology (2021) Vol. 29, Iss. 9, pp. 823-835
Open Access | Times Cited: 32
Type I Interferons in Systemic Autoimmune Diseases: Distinguishing Between Afferent and Efferent Functions for Precision Medicine and Individualized Treatment
François Chasset, Jean‐Michel Dayer, Carlo Chizzolini
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 31
The intersection of COVID-19 and autoimmunity: What is our current understanding?
Nicole Winchester, Cassandra Calabrese, Leonard H. Calabrese
Pathogens and Immunity (2021) Vol. 6, Iss. 1, pp. 31-54
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top